Johnson & Johnson’s subcutaneous Tremfya holds potential to set new standard in Crohn’s disease… EP News Bureau Oct 21, 2024 Tremfya's subcutaneous formulation may offer new flexibility for Crohn's disease treatment, positioning it as a key contender in…
